These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33248244)

  • 1. Novaferon, treatment in COVID-19 patients.
    Janapala RN; Patel J; Belfaqeeh O; Alhashmi A; Pourmand A
    Int J Infect Dis; 2021 Feb; 103():297. PubMed ID: 33248244
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "Novaferon, treatment in COVID-19 patients".
    Zheng F; Zhou Y; Zhou Z; Ye F; Huang B; Huang Y; Ma J; Zuo Q; Tan X; Xie J; Niu P; Wang W; Xu Y; Peng F; Zhou N; Cai C; Tang W; Xiao X; Li Y; Zhou Z; Jiang Y; Xie Y; Tan W; Gong G
    Int J Infect Dis; 2021 Feb; 103():336-337. PubMed ID: 33248243
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.
    Portela Sousa C; Brites C
    Braz J Infect Dis; 2020; 24(5):428-433. PubMed ID: 32866437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon deficiency can lead to severe COVID.
    Meffre E; Iwasaki A
    Nature; 2020 Nov; 587(7834):374-376. PubMed ID: 33139913
    [No Abstract]   [Full Text] [Related]  

  • 5. Type 1 interferons as a potential treatment against COVID-19.
    Sallard E; Lescure FX; Yazdanpanah Y; Mentre F; Peiffer-Smadja N
    Antiviral Res; 2020 Jun; 178():104791. PubMed ID: 32275914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19, interferons, and depression: A commentary.
    Shader RI
    Psychiatry Res; 2020 Sep; 291():113198. PubMed ID: 32535509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients.
    Koning R; Bastard P; Casanova JL; Brouwer MC; van de Beek D;
    Intensive Care Med; 2021 Jun; 47(6):704-706. PubMed ID: 33835207
    [No Abstract]   [Full Text] [Related]  

  • 8. The double edged interferon riddle in COVID-19 pathogenesis.
    Gupta R
    Crit Care; 2020 Nov; 24(1):631. PubMed ID: 33131507
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
    Yang S; Wu S; Yu Z; Huang J; Zhong X; Liu X; Zhu H; Xiao L; Deng Q; Sun W
    Immun Inflamm Dis; 2020 Dec; 8(4):753-762. PubMed ID: 33124193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
    Huang Q; Deng X; Li Y; Sun X; Chen Q; Xie M; Liu S; Qu H; Liu S; Wang L; He G; Gong Z
    Int J Clin Pharm; 2020 Jun; 42(3):837-845. PubMed ID: 32410206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for retinoids in the treatment of COVID-19?
    Trasino SE
    Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1765-1767. PubMed ID: 32459003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19).
    Tam PCK; Ly KM; Kernich ML; Spurrier N; Lawrence D; Gordon DL; Tucker EC
    Clin Infect Dis; 2021 Jan; 72(1):128-130. PubMed ID: 32472683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2/COVID-19, Lymphatic vessels, lymph, and lymphology.
    Witte MH; Daley SK
    Lymphology; 2020; 53(3):97-98. PubMed ID: 33350283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
    J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Stimulation With Recombinant Human Granulocyte Colony-Stimulating Factor for Coronavirus Disease 2019 (COVID-19)-Beware of Blind Spots.
    Meyer NJ; Lindell RB; Wherry EJ
    JAMA Intern Med; 2021 Jan; 181(1):78-80. PubMed ID: 32910155
    [No Abstract]   [Full Text] [Related]  

  • 17. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
    Chang R; Ng TB; Sun WZ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients.
    Tan C; Li S; Liang Y; Chen M; Liu J
    Braz J Infect Dis; 2020; 24(6):565-569. PubMed ID: 32950458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.